X-ray diffraction or XRD has shown a huge potential in new drug development, manufacturing and quality control of manufactured pharmaceutical formulations.
The greatest asset of the XRD technique is its non-destructive nature and therefore the sample is available for further analytical confirmations.
Pharmaceutical formulations are available as tablets, capsules, syrups, injectables, creams, lotions, aerosol sprays, etc X-ray diffraction provides valuable information on polymorphism, degree of crystallinity and amorphous character of solid formulations. In other words it is an ideal fingerprinting technique for such formulations.
The present article discusses some common applications of the technique during stages from drug development to manufacture of finished products.
A pharmaceutical formulation is a complex mixture of several compounds which comprise of the active drug ingredient together with other ingredients called excipients which act as fillers, binders, lubricants, colourants, sweeteners, disintergators, etc to achieve the desired properties of a dosage form.
The presence of a multitude of materials adds to the complexity of the formulation and a research scientist has to try out various permutations and combinations before the formulation is approved for commercialization.
XRD is certainly is helpful to the development chemist as it provides valuable details on degree of crystallinity and amorphous content of synthetic mixtures. Crystalline impurities present can be quantified down to 0.05% levels.
XRD data is accepted for new product registrations and patent applications. Single crystal structure of the active ingredient and powder pattern of the finished formulation are essential prerequisites for registration of new patents.
The development chemist has to collect important details on the following parameters before a product moves from laboratory to the manufacturing unit.
Crystal structure – The lattice type and dimensions of a unit cell need to be specified for the crystalline content
Polymorphism – Polymorphic content can impact properties such as solubility and dissolution rate, bioavailability and stability so it is important to collect details on polymorphic properties of ingredients of a drug material
Percentage of crystallinity – The percent crystallinity is a valuable parameter for drug dosage form. It has significant influence on manufacturing and processing as well as the pharmacological behaviour.
XRD tests can effectively determine the percent crystallinity by measuring the volume concentration of an amorphous filler to a crystalline active matrix within the pharmaceutical product’s dosage form
Compatibility with excipients – XRD makes it an ideal choice for studies on active drug- excipient combinations. A detailed study of the chosen excipients with active pharmaceutical ingredient is a must for consistency of properties such as drug release and bio- availability.
The general powder diffraction method can be used to successfully determine the crystal structure of a material, but usually, determining the dimensions and lattice type of the unit cell is sufficient for indexing.
This method of analysis is especially important when the polymorphs of certain registered drugs whose patents are about to expire have to be characterised. X-ray diffraction analysis also allows identifying the atomic structure within the unit cell, preferred orientation, site occupancy, etc.
The stability of a pharmaceutical compound can be characterised along with the occurrence of hydration and dehydration processes by carrying out in situ powder diffraction studies as a function of temperature and relative humidity. It is possible to carry out these XRD methods at any phase of the drug development process.
At our XRD testing labs, materials can be tested by subjecting them to conditions in which they will be actually used in specific applications. This is an important application of XRD analysis that helps to determine and monitor dosage uniformity.
The process to determine that involves analysing the actual percentages of each of the active ingredients in the final dosage form of the drug along with the percentage of other packing ingredients used in their amorphous or crystalline form.
Manufacturing Process Control
Manufacturing process can involve morphological changes in crystalline phase due to introduction of stress forces. Such changes can influence a drug’s bioavailability.
XRD analysis is quite useful in the analysis and monitoring of the crystal morphology of the excipients used in drug formulation. Through XRD method, any changes that may have occurred in the crystalline state of the excipients or the morphology of fillers in the final product can be detected. With the X’Celerator, the lower limit of detection has been significantly diminished for minority phases.
The nondestructive nature of XRD analysis makes it an ideal choice to fix the safe tableting pressure range so that the dosage form achieves its targeted dissolution rate and bio availability.
With its diverse range of applications XRD is gaining a high degree of popularity in pharmaceutical manufacturing and quality certifying laboratories.
1. How do you analyze XRD data?
Our team of experts interpret the results of the XRD data and help you answer important questions like material identification, crystal form or polymorph identification, detection and quantification of the degree of crystallinity of amorphous materials and even the percentage of different crystal forms in a mixture.
2. What make and model of XRD is available in your laboratory?
Our labs use the Xcelerator XRD Detector to conduct thorough testing of all kinds of pharmaceutical compounds. The crystal morphology of the samples can be thoroughly analyzed and monitored with the help of the Xcelerator XRD Detector. This model is completely state-of-the-art and has managed to diminish the lower limit of detection quite significantly.
3. What is the sample quantity required for Powder XRD?
The quantity of sample required depends on the type of analysis to be performed. If only a simple XRD diffractogram is needed it can be done with as little as 1 gm of powder sample or even less depending on the nature of the material.
4. Could you test for asbestos in talcum with XRD?
Our lab routinely conducts the test for asbestos in talcum powder following the recommended pharmacopoeial, ISO and BIS methods.
5. Can you do polymorph identification with XRD?
Yes, the XRD method is fully capable of conducting polymorph identification tests on its own. Polymorphic content can affect a lot of the different properties of the material, such as solubility, dissolution rate, bioavailability, and compound stability. The XRD test is perfectly suited to find out more about the polymorphic properties of any compound or a drug material.